Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Neurol Sci ; 43(11): 6449-6460, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35945382

ABSTRACT

BACKGROUND: Susac syndrome (SS) is a rare endotheliopathy with an estimated prevalence of 0.14-0.024 per 100,000. It is an important differential diagnosis in demyelinating disorders. There are few case series and no large randomized controlled trials, and most reports come from developed countries. We report six cases of SS in three centers in Brazil and discuss management challenges in emergent countries. METHODS: This is a retrospective case series of patients diagnosed with SS in three medical centers in Brazil between April 2018 and July 2021. The European Susac consortium (EuSaC) criteria were used for diagnosis of SS. Demographic data and clinical interventions were described and outcomes were assessed subjectively and by applying the modified Rankin Scale (mRS) on last follow-up. RESULTS: Six patients were diagnosed with SS (3 males, 3 females). Mean age at presentation was 36 years (range 17 to 54). The most common initial symptom was confusion, followed by visual impairment and hearing loss. Characteristic snowball lesions on magnetic resonance imaging (MRI) were present in four patients (66%). Retinal artery abnormalities were present in half (3/6) of patients, and sensorineural hearing loss was present in four patients (66%). Outcome was favorable (mRS ≤ 2) in five patients (86%). Patients treated early had a more favorable outcome. CONCLUSION: Emergent countries face challenges in the diagnosis and management of patients with SS, such as access to advanced tests (fluorescein angiography, serial MRI) and treatment drugs (rituximab, mycophenolate). Further research should consider particularities of patients with SS in emergent countries.


Subject(s)
Susac Syndrome , Male , Female , Humans , Adolescent , Young Adult , Adult , Middle Aged , Susac Syndrome/diagnosis , Susac Syndrome/epidemiology , Susac Syndrome/therapy , Retrospective Studies , Brazil/epidemiology , Magnetic Resonance Imaging/methods , Confusion
2.
Autoimmun Rev ; 13(4-5): 347-50, 2014.
Article in English | MEDLINE | ID: mdl-24424186

ABSTRACT

Susac syndrome (SS) is an autoimmune disease characterized by the clinical triad of encephalopathy, branch retinal artery occlusions and neuro-sensorial hearing loss; it is due to a microangiopathy affecting the precapillary arterioles of the brain, retina and inner ear. SS is characterized by typical radiological features on magnetic resonance imaging (MRI) which, together with clinical symptoms, may permit a diagnosis. Branch retinal artery occlusions (BRAOs) are best evaluated using fluorescein angiography (FA) which may show the typical multifocal fluorescence. SS is an autoimmune endotheliopathy that requires treatment with immunosuppressive agents: steroids, azathioprine, mycophenolate mofetil, methotrexate, cyclophosphamide and intravenous immunoglobulin, usually in combination. Plasma exchange is also useful. In addition, antiplatelet agents may be a useful adjunct. Correct immunosuppressive therapy results in significant clinical and radiological improvement. An early diagnosis and treatment are important to delay the disease progression and prevent permanent disability.


Subject(s)
Susac Syndrome/diagnosis , Brain/blood supply , Brain/pathology , Hearing Loss/drug therapy , Hearing Loss/pathology , Humans , Magnetic Resonance Imaging , Retinal Artery Occlusion/diagnosis , Retinal Artery Occlusion/drug therapy , Retinal Artery Occlusion/pathology , Susac Syndrome/classification , Susac Syndrome/epidemiology
3.
Autoimmun Rev ; 10(9): 548-52, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21515413

ABSTRACT

Susac's syndrome is an infrequent neurological disorder characterized by the clinical triad of encephalopathy, hearing loss, and branch retinal artery occlusions. Its pathophysiology is not entirely clear, although it is now thought that it is most probably an immune-mediated endotheliopathy that affects the microvasculature of the brain, retina, and inner ear. An early diagnosis is important as treatment can halt disease progression and prevent permanent disability.


Subject(s)
Susac Syndrome , Humans , Prognosis , Susac Syndrome/diagnosis , Susac Syndrome/epidemiology , Susac Syndrome/immunology , Susac Syndrome/pathology , Susac Syndrome/therapy
SELECTION OF CITATIONS
SEARCH DETAIL